Sponsors
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Introduced March 3, 2025 by Frank Pallone · Last progress March 3, 2025
Creates many new federal programs, reporting requirements, and regulations across environment, consumer safety, communications, public health, and health care. It funds recycling and composting studies and pilot grants, bans certain high‑concentration consumer sodium nitrite products, sets battery safety standards, tightens telecom and satellite rules for foreign control, and requires supply‑chain and blockchain advisory bodies. Imposes large health-sector reforms: new transparency and reporting rules for pharmacy benefit managers (PBMs) across ERISA, the Internal Revenue Code, and the Public Health Service Act; changes to Medicaid and Medicare payment, pharmacy pricing surveys, Part D pharmacy access rules, hospital and DSH payment adjustments, telehealth and home infusion coverage, and multiple public‑health preparedness, surveillance, and NIH/FDA programs. The bill contains many deadlines, new enforcement tools, and specific FY2025–FY2029 funding authorizations for program implementation.
The bill advances broad consumer protections, health‑care access, public‑health preparedness, and drug‑pricing transparency, but does so through sizable new spending and extensive reporting/compliance rules that create administrative costs, privacy risks, and competitive pressures that may disproportionately burden smaller providers and state/local implementers.
Patients, employers, and plan sponsors gain far greater transparency into drug pricing, PBM fees, rebates, and plan spending through standardized, machine-readable and participant-facing reporting, enabling better contract negotiation and oversight that can lower net drug costs over time.
Medicare beneficiaries and people who rely on local care retain or gain access to services—through extended telehealth flexibilities, home infusion coverage, essential retail pharmacy protections, and temporary Medicare payment increases—helping preserve access to care for seniors, rural residents, and chronically ill patients.
State and local public‑health systems, hospitals, and emergency responders receive strengthened preparedness funding, national stockpile and regional lab support, wastewater surveillance grants, and national planning for diagnostics and countermeasures—improving readiness for pandemics and other public‑health emergencies.
Taxpayers face substantially higher federal spending from many new authorizations, appropriations, and multi‑year funding commitments across public health, community health centers, broadband, and other programs.
States, providers, plans, PBMs, pharmacies, and local governments will incur significant new reporting, auditing, and compliance burdens (and risk of withheld matching funds), creating recurring administrative costs and diverting staff time from service delivery.
Steep fines, heavy reporting requirements, and technical standards risk squeezing out smaller providers, PBMs, pharmacies, and new broadband entrants—raising compliance costs that may drive consolidation, reduce competition, or limit local service options.